AJP - Endocrinology and Metabolism, Vol 262, Issue 4 E417-E426, Copyright © 1992 by American Physiological Society

ARTICLES

Inhibition of phosphatidylinositol synthase by glucose in human retinal pigment epithelial cells

J. Nakamura, M. A. Del Monte, D. Shewach, S. A. Lattimer and D. A. Greene
Department of Internal Medicine, University of Michigan, Ann Arbor 48109.

A series of interrelated biochemical and functional defects, induced by hyperglycemia, associated with intracellular depletion of D-myo-inositol, and corrected by aldose reductase inhibitors, have been ascribed to abnormal phosphoinositide metabolism in several tissues prone to diabetic complications. However, reductions in tissue D-myo-inositol content are not universally found in complications-prone diabetic tissues, and direct mass-action effects of cellular D-myo-inositol depletion on the critical CDPdiacylglycerol-inositol 3-phosphatidyltransferase (PI synthase; EC 2.7.8.11) step have never been shown conclusively in relevant cells. The studies reported here simultaneously estimated the chemical mass of CDP diglyceride by equilibrium labeling with 5-[3H]cytidine and phosphoinositide biosynthesis by the incorporation of [32P]orthophosphate into phosphoinositide. This was done to assess the degree of inhibition of PI synthase under various degrees of D-myo-inositol depletion and sorbitol accumulation induced by glucose and other metabolic manipulations in cultured human retinal pigment epithelial cells, a new in vitro model for diabetic complications. The results suggest that sorbitol accumulation limits the PI synthase reaction in these cells by selectively depleting specific intracellular pools of D-myo-inositol and/or by possible independent effects of sorbitol on PI synthase.

This article has been cited by other articles:

				R. Pop-Busui, V. Marinescu, C. Van Huysen, F. Li, K. Sullivan, D. A. Greene, D. Larkin, and M. J. Stevens Dissection of Metabolic, Vascular, and Nerve Conduction Interrelationships in Experimental Diabetic Neuropathy by Cyclooxygenase Inhibition and Acetyl-L-Carnitine Administration Diabetes, August 1, 2002; 51(8): 2619 - 2628. [Abstract] [Full Text] [PDF]

				M. J. Stevens, Y. Hosaka, J. A. Masterson, S. M. Jones, T. P. Thomas, and D. D. Larkin Downregulation of the human taurine transporter by glucose in cultured retinal pigment epithelial cells Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E760 - E771. [Abstract] [Full Text] [PDF]

				F. Porcellati, Y. Hosaka, T. Hlaing, M. Togawa, D. D. Larkin, A. Karihaloo, M. J. Stevens, P. D. Killen, and D. A. Greene Alternate splicing in human Na+-MI cotransporter gene yields differentially regulated transport isoforms Am J Physiol Cell Physiol, June 1, 1999; 276(6): C1325 - C1337. [Abstract] [Full Text] [PDF]

				F. Porcellati, T. Hlaing, M. Togawa, M. J. Stevens, D. D. Larkin, Y. Hosaka, T. W. Glover, D. N. Henry, D. A. Greene, and P. D. Killen Human Na+-myo-inositol cotransporter gene: alternate splicing generates diverse transcripts Am J Physiol Cell Physiol, May 1, 1998; 274(5): C1215 - C1225. [Abstract] [Full Text] [PDF]